Rajan Sharma
Stock Analyst at Goldman Sachs
(0.12)
# 4,397
Out of 5,042 analysts
5
Total ratings
25%
Success rate
-29.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $15.41 | -52.95% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $83.29 | +16.46% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $43.24 | +8.70% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $33.18 | +138.10% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $15.41
Upside: -52.95%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $83.29
Upside: +16.46%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $43.24
Upside: +8.70%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $33.18
Upside: +138.10%